Originally published by our sister publication Specialty Pharmacy Continuum
Lindsey P. Sheehan, PharmD
An emergency department (ED)-focused, specialty pharmacist–led program for management of hepatitis C virus (HCV) at the University of Kentucky (UK) achieved more than a sixfold increase in direct-acting antiviral (DAA) treatment uptake and avoided time-to-treatment delays that sometimes exceeded one year prior to the program’s launch, leaders of the initiative reported